Raycaster is an AI‑native workspace for biopharma regulatory, clinical, CMC, and quality teams that ingests protocols, CSRs, Module 2/3 reports, SOPs, and guidance to enable natural‑language search with exact citations. It automates drafting of key regulatory documents from templates and data, and instantly maps any change in endpoints, limits, or process parameters to all affected dossier sections, keeping submissions consistent and reducing rework.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SSFounders
Product
Problem
Biopharma teams spend extensive time manually aligning regulatory, clinical, CMC, and quality documents, leading to version drift, duplicated effort, and delayed submissions. Updating a single parameter often requires a time‑consuming search across multiple dossiers to identify impacted sections.
Solution
Raycaster provides an AI‑native workspace that ingests protocols, CSRs, Module 2/3 reports, SOPs, and regulatory guidance, enabling natural‑language queries that surface regional requirements, impacted document sections, and citation details. The platform can generate draft content for protocols, amendments, IBs, CSRs, control strategies, validation reports, and other regulatory deliverables from templates and source data, while keeping writers in control of final edits. When a study endpoint, limit, or process parameter changes, Raycaster automatically traces the impact across all linked documents and proposes aligned updates, ensuring consistency throughout the dossier. Integrated AI tools operate directly within Word, Excel, PowerPoint, and PDF, allowing users to search, draft, and revise without leaving their files. The solution supports both pay‑as‑you‑go usage and subscription plans, with enterprise options offering advanced security, SSO, and workflow governance.
Target Audience
Primary users are regulatory, clinical, CMC, and quality teams within biopharma companies that produce IND, NDA, and lifecycle submission dossiers.
Features
- AI‑driven semantic search across protocols, CSRs, Module 2/3, SOPs, and regulatory guidance with citation to exact paragraphs
- Automated drafting of regulatory documents (protocols, amendments, IBs, CSRs, control strategies, validation reports) from templates and structured data
- Impact analysis engine that maps changes in endpoints, limits, or process parameters to all affected dossier sections
- In‑app AI assistance for search, generation, and editing within Word, Excel, PowerPoint, and PDF files
- Role‑based access controls, encryption in transit and at rest, SOC 2 compliance, with optional SSO and enterprise governance
- Pay‑as‑you‑go credit model and tiered subscription (Plus) with increased AI usage, project limits, and storage